Дата:	--/--/-- --:--:--
Id события:	4AYN1AQR
Тип действия:	ACQUISITION
Статус действия:	ANNOUNCED
Символ покупателя:
Целевой символ:	AKCA
Обновлено:	--/--/-- --:--:--
Цена покупки за акцию:	18.15
Цена за акцию в валюте:	USD
Ссылки на новости:	http://www.prnewswire.com/news-releases/ionis-pharmaceuticals-to-acquire-remaining-stake-in-akcea-therapeutics-301120837.html

Action Notes

-- Ionis Pharmaceuticals, Inc. and its affiliate Akcea Therapeutics, Inc. today announced that they have entered into a definitive agreement under which Ionis will acquire all of the outstanding shares of Akcea common stock it does not already own, approximately 24%, for $18.15 per share in cash. Promptly following the completion of the tender offer, Ionis will acquire all remaining shares of Akcea common stock at the same price of $18.15 per share in cash through a second-step merger. Ionis and Akcea expect to complete the transaction in the fourth quarter of 2020, subject to other customary closing conditions.Ionis and Akcea expect to complete the transaction in the fourth quarter of 2020, subject to other customary closing conditions.